{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:58:22Z","timestamp":1786993102064,"version":"build-2736575974"},"reference-count":14,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Gynecology Obstetrics and Human Reproduction"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.jogoh.2017.08.005","type":"journal-article","created":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T13:02:37Z","timestamp":1504270957000},"page":"697-699","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Is anagrelide safe during pregnancy?"],"prefix":"10.1016","volume":"46","author":[{"given":"N.","family":"Cornet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Vialard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Mir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Berveiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jogoh.2017.08.005_bib0075","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ejogrb.2011.04.040","article-title":"Essential thrombocythemia and pregnancy","volume":"158","author":"Valera","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.jogoh.2017.08.005_bib0080","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/ajh.21508","article-title":"Essential thrombocythemia and pregnancy: observations from recent studies and management recommendations","volume":"84","author":"Tefferi","year":"2009","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jogoh.2017.08.005_bib0085","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1182\/blood-2007-04-083501","article-title":"Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia and primary myelofibrosis: recommendations from an ad hoc international expert panel","volume":"110","author":"Tefferi","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jogoh.2017.08.005_bib0090","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1182\/blood-2010-08-270033","article-title":"How I treat essential thrombocythemia","volume":"117","author":"Beer","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jogoh.2017.08.005_bib0095","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1038\/leu.2008.177","article-title":"Evidence and expertise in the management of polycythemia vera and essential thrombocythemia","volume":"22","author":"Finazzi","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.jogoh.2017.08.005_bib0100","unstructured":"http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2013\/020333s020lbl.pdf. [accessed 26.04.2017]."},{"key":"10.1016\/j.jogoh.2017.08.005_bib0105","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1365-2141.2005.05400.x","article-title":"Pregnancy and its management in the Philadelphia negative myeloproliferative diseases","volume":"129","author":"Harrison","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jogoh.2017.08.005_bib0110","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1182\/asheducation-2006.1.246","article-title":"Myeloproliferative disease in pregnancy and other management issues","author":"Barbui","year":"2006","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jogoh.2017.08.005_bib0115","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1034\/j.1600-0609.2001.00367.x","article-title":"A single institutional experience with 43 pregnancies in essential thrombocythemia","volume":"66","author":"Wright","year":"2001","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jogoh.2017.08.005_bib0120","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1007\/s00277-004-0904-5","article-title":"Anagrelide therapy in pregnancy: report of a case of essential thrombocythemia","volume":"83","author":"Doubek","year":"2004","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jogoh.2017.08.005_bib0125","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1007\/s00277-005-1059-8","article-title":"Successful outcome with anagrelide in pregnancy","volume":"84","author":"Alkindi","year":"2005","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jogoh.2017.08.005_bib0130","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000253030","article-title":"Anagrelide treatment in early pregnancy in a patient with JAK2V617F-positive essential thrombocythemia: case report and literature review","volume":"122","author":"Sobas","year":"2009","journal-title":"Acta Haematol"},{"key":"10.1016\/j.jogoh.2017.08.005_bib0135","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1182\/blood-2005-08-3526","article-title":"Molecular basis of the diagnosis and treatment of polycythemia vera and essential thrombocythemia","volume":"107","author":"Schafer","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jogoh.2017.08.005_bib0140","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"}],"container-title":["Journal of Gynecology Obstetrics and Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468784717301605?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468784717301605?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,6]],"date-time":"2021-11-06T18:10:27Z","timestamp":1636222227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468784717301605"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":14,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S2468784717301605"],"URL":"https:\/\/doi.org\/10.1016\/j.jogoh.2017.08.005","relation":{},"ISSN":["2468-7847"],"issn-type":[{"value":"2468-7847","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is anagrelide safe during pregnancy?","name":"articletitle","label":"Article Title"},{"value":"Journal of Gynecology Obstetrics and Human Reproduction","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jogoh.2017.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}